|
 |
European Pharmaceutical Contractor
|
An Important Pharmaceutical Science Initiative
The European Federation of Pharmaceutical Sciences (EUFEPS) launched the New Safe Medicines Faster (NSMF) initiative in 2000. Its aim is to provide a dedicated focus for the pharmaceutical sciences sector for participating in the European Community Research and Development Framework Programme for the period 2002 to 2006. This article briefly describes the NSMF project and the progress made to date.
Traditionally, pharmaceutical companies headquartered in Europe have played a leading role in the development of new drugs. However, there is evidence that this may no longer be true. Accordingly, initiatives are needed to reverse this trend. To get started, in 1999 EUFEPS produced a position paper entitled New Safe Medicines Faster.
In 2000, EUFEPS established the New Safe Medicines Faster Project, the ultimate goal of which is to contribute to the more effective development of medicines for the benefit of European citizens. In a workshop jointly sponsored by EUFEPS and the European Commission, held in Brussels in March 2000, ideas and suggestions for research topics, methodologies, techniques and other means of promoting the drug development process were identified, put together and published in the workshop report. In the future, the following will be of paramount importance:
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Evolution Summit 2010
27-29 October 2010, Montreux, Switzerland
Amidst attrition challenges and pressures from stakeholders, the laurels are up for grabs for the next leaders in drug development. While the industry is struggling to achieve financial sustainability and operational viability, it is awaiting the leadership of a new bold visionary who will bring fundamental innovation to overhauling the research approaches of the past. When gearing up for the future, pharmaceutical and biopharmaceutical companies continue securing long-lasting lucrative partnerships along their value chains. Incorporating novel development paradigms and improving internal decision-making pave the way to shorter timelines and growing profit margins.
More info >> |
|
 |
News and Press Releases |
 |
Almac launch Biomarkers for biopharma
Almac today announced the launch of Biomarkers for biopharma; a range of solutions specifically designed to meet the needs of the biopharma industry. Almac’s solutions are to support biopharma companies in adopting biomarker strategies to enable them to better understand their drug, improve their drug’s success rate, improve the drug’s value and ultimately maximise their drug’s potential.
More info >> |
|
 |
